-
-
Forbes (March 10, 2023) Accelerating Drug Development To Keep Pace With Drug Discovery
The pharmaceutical industry invests heavily in technologies—$57.4 billion in 2022 alone—to discover new therapies to treat our greatest health challenges. Yet drug development teams are still using the same antiquated, manual processes to move those life-changing therapies toward commercialization.
The New Indian Express (March 10, 2023) Startup develops chip for drug screening of cancer patients
Chennai-based startup ISMO Bio-Photonics has developed a palm-sized 3D-printed microfluidic chip to provide personalized drug screening for cancer patients.
Endpoint News (March 6, 2023) Pharma industry lobbies Congress for solution to primate shortage after indictments for alleged smuggling
The US Fish and Wildlife Service has been denying applications to import non-human primates for the past few weeks, and it’s creating a “crisis,” the National Association for Biomedical Research (NABR) said in a letter lobbying Congress released this week.
The Wall Street Journal (March 3, 2023) Monkey Business Threatens U.S. Drug Discovery
A shortage of farm-bred primates is contributing to poaching and harming biomedical research and development.
-
- You must be logged in to reply to this topic.